NCT05749601

Brief Summary

Clinical study regarding the incidence and severity of knee osteoarthritis (KOA) in a certain area from South-Eastern Europe. Aim of the clinical study: to determine the KOA grade through X-Ray studies, to perform nuclear magnetic resonance (NMR) analysis to assess the KOA severity and to determine the level of significant parameters in the synovial liquid extracted from the patients presenting KOA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 19, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 1, 2023

Completed
Last Updated

March 3, 2023

Status Verified

March 1, 2023

Enrollment Period

4 months

First QC Date

October 19, 2022

Last Update Submit

March 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The influence of metabolic syndrome parametres and environment of origin in KOA severity

    In this part of the study I included 85 patients for whom I measure the parameters of the metabolic syndrome: a high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride, total cholesterol and body mass index (BMI) and I made the corelation of knee osteoarthritis (KOA) Kellgren-Lawrence radiological classification (KL). The formula form BMI was kg/ m2. I raported the influence of the environment of origin in relation to the severity of KOA, performing the statistical analysis of the obtained data, applied metod ANOVA, specific ordinal and binomial logistic regression models, p value \<0,005. 95% confidence interval, without non-inferiority/equivalence test.

    up 2 weeks

Secondary Outcomes (1)

  • The influence of patellofemoral morphology in KOA severity

    1 week

Other Outcomes (1)

  • The influence of reactive oxygen species (ROS) level in KOA severity

    3 weeks

Study Arms (5)

Patients without knee osteoarthritis (KOA) grade 0

ACTIVE COMPARATOR

Patient without knee affection

Other: Influence of the metabolic syndrome (MetS) parameters on knee osteoarthritis (KOA) severity, the assesment of the reactive oxygen species and reactive nitrogen species in knee synovial fluidOther: The influence of patellofemoral morphology in the radiological severity of knee osteoarthritisOther: The influence of ROS from the synovial fluid on the severity of KOA

Patients with KOA grade I

EXPERIMENTAL

Kellgren-Lawrence classification (KL) grade I- doubtful narrowing of the joint space and possible osteophytes

Other: Influence of the metabolic syndrome (MetS) parameters on knee osteoarthritis (KOA) severity, the assesment of the reactive oxygen species and reactive nitrogen species in knee synovial fluidOther: The influence of patellofemoral morphology in the radiological severity of knee osteoarthritisOther: The influence of ROS from the synovial fluid on the severity of KOA

Patients with KOA grade II

EXPERIMENTAL

KL grade II - definite osteophytes and possible narrowing of joint space.

Other: Influence of the metabolic syndrome (MetS) parameters on knee osteoarthritis (KOA) severity, the assesment of the reactive oxygen species and reactive nitrogen species in knee synovial fluidOther: The influence of patellofemoral morphology in the radiological severity of knee osteoarthritisOther: The influence of ROS from the synovial fluid on the severity of KOA

Patients with KOA grade III

EXPERIMENTAL

KL grade III- definite narrowing of the joint space, significant osteophytosis, and possible bone deformities.

Other: Influence of the metabolic syndrome (MetS) parameters on knee osteoarthritis (KOA) severity, the assesment of the reactive oxygen species and reactive nitrogen species in knee synovial fluidOther: The influence of patellofemoral morphology in the radiological severity of knee osteoarthritisOther: The influence of ROS from the synovial fluid on the severity of KOA

Patients with KOA grade IV

EXPERIMENTAL

KL grade IV- marked joint space narrowing accompanied by deformities, bone sclerosis, and large osteophytes

Other: Influence of the metabolic syndrome (MetS) parameters on knee osteoarthritis (KOA) severity, the assesment of the reactive oxygen species and reactive nitrogen species in knee synovial fluidOther: The influence of patellofemoral morphology in the radiological severity of knee osteoarthritisOther: The influence of ROS from the synovial fluid on the severity of KOA

Interventions

Highlighting the influence of environment of origin on KOA incidence and corelated impact of high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, triglycerides and body mass index (BMI). The analytes from synovial fluid were determined by fluorometric method.

Patients with KOA grade IPatients with KOA grade IIPatients with KOA grade IIIPatients with KOA grade IVPatients without knee osteoarthritis (KOA) grade 0

Highlighting the influence of distal femoral torsion angle, patellofemoral congruence angle and sulcus angle, in KOA severity under the influence of sex and age.

Patients with KOA grade IPatients with KOA grade IIPatients with KOA grade IIIPatients with KOA grade IVPatients without knee osteoarthritis (KOA) grade 0

Highlighting the influence of ROS from the synovial fluid in KOA severity under the influence of some biochemicals blood constants.

Patients with KOA grade IPatients with KOA grade IIPatients with KOA grade IIIPatients with KOA grade IVPatients without knee osteoarthritis (KOA) grade 0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male and female with knee pain (complaints); presented symptoms and clinical signs corresponding to KOA and had knee X-rays in the anteroposterior view and nuclear magnetic resonance (NMR) performed for setting the diagnosis with unilateral or bilateral knee pain; patients with clinically determined and recorded values of total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides and the glycemia in the clinical observation sheet.

You may not qualify if:

  • patients presenting lower limb arthroplasties; history of lower limb or pelvis fractures and previous knee surgery: ligamentoplasty, meniscectomy; inflammatory rheumatic diseases such as rheumatoid polyarthritis; other major conditions like malignant illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

3 "Iacob Czihac" Emergency Military Clinical Hospital, 7-9 General Henri Mathias Berthelot St., 700483 Iasi, Romania

Iași, Romania

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

ETV3 protein, humanReactive Nitrogen Species

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Free RadicalsInorganic ChemicalsNitrogen CompoundsOrganic ChemicalsNitroso Compounds

Study Officials

  • Nicoleta B Tudorachi, MD

    "Ovidius" University of Constanța, Romania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2022

First Posted

March 1, 2023

Study Start

March 1, 2022

Primary Completion

June 16, 2022

Study Completion

August 19, 2022

Last Updated

March 3, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations